The impact of NK1 receptor antagonist selection on chemotherapy-related adverse events: a retrospective study of adverse events in paclitaxel or nab-paclitaxel and carboplatin combination therapy with fosnetupitant and aprepitant use. - Yamaoka K; Kajita S; Kume M; Hirabatake M; Sato Y; Hashida T; Tachikawa R; Muroi N (Frontiers in pharmacology, 2026)